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Tumor necrosis factor alpha (TNFα), a pro-inflammatory cytokine, plays a significant
role in the pathogenesis of allergic asthma. Inhalation of TNFα also induces airway
hyperresponsiveness in healthy human subjects, and the underlying mechanism is not
fully understood. A recent study reported that TNFα caused airway inflammation and a
sustained elevation of pulmonary chemoreflex responses in mice, suggesting a possible
involvement of heightened sensitivity of vagal pulmonary C-fibers. To investigate this
possibility, the present study aimed to investigate the effect of a pretreatment with TNFα
on the sensitivity of vagal pulmonary afferents in anesthetized mice. After TNFα (10 µg/ml,
0.03 ml) and vehicle (Veh; phosphate buffered saline (PBS), 0.03 ml) were administered
by intra-tracheal instillation in each mouse of treated (TNF) and control (Veh) groups,
respectively, the peak activity of pulmonary C-fibers in response to an intravenous bolus
injection of a low dose of capsaicin (Cap; 0.5 µg/kg) was significantly elevated in TNF
group (6.5 ± 1.3 impulses/s, n = 12) 24–48 h later, compared to that in Veh group (2.2
± 0.5 impulses/s, n = 11; P < 0.05). Interestingly, the same low dose of Cap injection
also evoked a distinct burst of discharge (2.4 ± 0.7 impulses/s) in 75% of the silent
rapidly adapting receptors (RARs), a subtype of RARs exhibiting no phasic activity, in TNF
group, but did not stimulate any of the silent RARs in Veh group. To further determine
if this sensitizing effect involves a direct action of TNFα on these sensory nerves, the
change in intracellular Ca2+ concentration in response to Cap challenge was measured
in isolated mouse vagal pulmonary sensory neurons. The Cap-evoked Ca2+ influx was
markedly enhanced in the neurons incubated with TNFα (50 ng/ml) for ∼24 h, and this
sensitizing effect was attenuated in the neurons isolated from the TNF-receptor double
homozygous mutant mice. In conclusion, the TNFα pretreatment enhanced the Cap
sensitivity in both pulmonary C-fibers and silent RARs, and the action was mediated
through TNF receptors. These sensitizing effects of TNFα may contribute, at least in
part, to the pathogenesis of airway hyperresponsiveness induced by this cytokine.
Keywords: airway, lung, C-fiber, rapidly adapting receptor, cytokine, inflammation, asthma

INTRODUCTION
It is well-documented that tumor necrosis factor alpha (TNFα), a pro-inflammatory cytokine, plays
a significant role in the pathogenesis of chronic airway inflammatory diseases such as allergic
asthma (Thomas, 2001; Howarth et al., 2005; Berry et al., 2006; Heffler et al., 2007; Brightling
et al., 2008). Inhalation of aerosolized TNFα can also induce bronchial hyperresponsiveness
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To answer these questions, the first study series was designed
to determine the effect of intra-tracheal administration of TNFα
into the lung on the sensitivity of vagal bronchopulmonary
afferents to capsaicin (Cap), a selective TRPV1 agonist (Caterina
et al., 1997; Nilius et al., 2007), in anesthetized mice 24–48 h
later, using the single-fiber recording technique. Because of the
diverse actions of TNFα on a number of other target cells in the
airways including neutrophils, eosinophils, and endothelial cells
(Thomas, 2001), it was impossible to determine if the sensitizing
effect is mediated through a direct action of TNFα on these
neurons in a whole-animal preparation. Therefore, in the second
study series the effect of TNFα was determined in isolated mouse
pulmonary sensory neurons using the Ca2+ imaging technique.
A possible involvement of TNF receptors was further investigated
in mice in which both types of TNF receptors were mutated.

accompanied by airway inflammation in healthy human subjects
(Thomas et al., 1995), but the underlying mechanism is not fully
understood. One of the prominent pathophysiological features
of inflammation-induced bronchial hyperresponsiveness is a
heightened sensitivity of airway sensory nerves (Lee and Yu,
2014; Mazzone and Undem, 2016). A recent study carried out in
our laboratory has demonstrated that intra-tracheal instillation
of TNFα 24 h earlier caused airway inflammation and a sustained
(>48 h) elevation of pulmonary chemoreflex sensitivity in mice
(Lin et al., 2013). Because pulmonary chemoreflexes are known
to be elicited by stimulation of vagal bronchopulmonary C-fiber
afferents (Lee and Pisarri, 2001), this finding suggested a possible
involvement of these vagal afferents (Lin et al., 2013). However,
whether the sensitivity of these afferents is actually elevated
following the TNFα treatment in intact animals remains to be
determined.
Previous investigators have shown that the TNFα treatment
induced a sensitizing effect on the nociceptive neurons in
dorsal root ganglia (DRG), the counterpart of pulmonary Cfiber neurons innervating other organs, and contributed to the
development of lingering inflammatory pain in somatic tissues
(Cunha et al., 1992; Nicol et al., 1997). It has been suggested that
this hyperalgesic effect was mediated through an action on the
TNF receptors, TNFR1 and TNFR2, on the cell surface, and an
increase in the sensitivity and/or expression of transient receptor
potential vanilloid type 1 (TRPV1) receptors in DRG neurons
(Heffler et al., 2007). Whether the same mechanism is involved in
the TNFα-induced hypersensitivity of vagal pulmonary afferents
is not yet known.
Among the three major types of vagal bronchopulmonary
afferents, C-fiber represents the majority (Jammes et al., 1982)
and plays an important role in the regulation of cardiopulmonary
function in both healthy and disease conditions (Coleridge and
Coleridge, 1984; Lee and Pisarri, 2001). Bronchopulmonary
C-fibers can be activated by various endogenous inflammatory
mediators and inhaled chemical irritants; stimulation of these
afferents elicits an array of powerful reflex responses including
cough, bronchoconstriction, and airway hypersecretion
(Coleridge and Coleridge, 1984; Lee and Pisarri, 2001; Lee
and Yu, 2014); intense and/or sustained stimulation can lead
to neurogenic inflammation (Baluk et al., 1992; De Swert
and Joos, 2006). Thus, when the sensitivity of these afferents
is elevated, a mild stimulus may trigger exaggerated reflex
responses, and contribute to the airway hyperresponsiveness.
One of the characteristic traits of these C-fiber sensory neurons
is an abundant expression of the TRPV1 channel, a polymodal
transducer involved in the manifestation of various symptoms
of airway hypersensitivity (Geppetti et al., 2006; Lee and Gu,
2009). The other two major types of vagal bronchopulmonary
sensory receptors, rapidly adapting receptors (RARs) and
slowly adapting receptors (SARs), are myelinated afferents and
function primarily as mechanoreceptors (Lee and Yu, 2014).
However, an unexpected expression of TRPV1 in RARs and
SARs resulting from chronic allergic airway inflammation has
been reported in rats (Zhang et al., 2008). Whether this may
occur in the TNFα-induced airway inflammation in mice is not
known.
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METHODS AND MATERIALS
This study consisted of both in vivo and in vitro experiments. The
experimental procedures described below were in accordance
with the recommendation in Guide for the Care and Use
of Laboratory Animals published by the National Institutes
of Health, and also approved by the University of Kentucky
Institutional Animal Care and Use Committee.

In-vivo Study
Pretreatment with TNFα
Young male C57BL6/J mice (12-wk old) were anesthetized by
inhalation of vaporized isoflurane (2% in O2 ) via a nosecone.
After a small (∼2 mm) mid-line incision was made on the ventral
neck skin to expose the trachea, a small volume (0.03 ml) of
TNFα (10 µg/ml) or phosphate buffered saline (PBS) was instilled
into the trachea via a 28-gauge needle, and the incision was then
closed by tissue adhesive (Vetbond, 3M, St. Paul, MN, USA).
This dose of TNFα was chosen based upon our pilot experiments
performed in an earlier study (Lin et al., 2013) to determine the
minimal dose required to induce airway hypersensitivity in mice.
Morton and coworkers have recently reported a similar dose of
TNFα to be effective in generating airway inflammation in mice
(Morton et al., 2016). Experiments were carried out 24–48 h later.

Animal Preparation
Mice were initially anesthetized with an intraperitoneal injection
of α-chloralose (70 µg/g) and urethane (1 mg/g) dissolved in a
2% borax solution; supplemental doses (one-tenth of the initial
dose) of the same anesthetics were injected intravenously (iv)
to maintain abolition of pain reflexes induced by tail-pinch.
For administration of pharmacological agent (s), a catheter was
inserted into the left jugular vein and advanced until its tip was
positioned just above the right atrium. A catheter was inserted
into femoral artery and connected to a pressure transducer
(P23AA, Statham, Hato Rey, Puerto Rico) for recording the
arterial blood pressure (ABP) and heart rate (HR). A short
tracheal cannula was inserted just below the larynx via a
tracheotomy. Tracheal pressure (PT ) was continuously recorded
(MP45-28, Validyne, Northridge, CA, USA) via a side-port of the
tracheal cannula. After a midline thoracotomy was performed,
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the lung was artificially ventilated with a respirator (Model
845, Hugo Sachs Elektronik, March, Germany); the expiratory
outlet of the respirator was placed under 3-cmH2 O pressure to
maintain a stable and near-normal functional residual capacity.
Tidal volume (VT ) and respiratory rate were set at 8 µl/g and 180
breaths/min, respectively, to mimic those of anesthetized mice.
Body temperature was maintained at ∼36◦ C by means of heating
pad placed under the animal lying in a supine position.

The FA signal was recorded continuously at a sampling rate of
3–20 kHz and analyzed by a computer and a data acquisition
system (Biocybernetics TS-100) for 20 s before and 60 s after
each injection. Baseline FA was averaged over the 10-s period
immediately preceding the Cap injection, and the peak response
was defined as the highest FA averaged over 2-s duration (or 6
breaths) within the first 5 s after the injection.
The general locations of these sensory receptors in the lung
structure were identified by their responses to the gentle pressing
of the outer surface of the lung with a blunt-ended glass rod at
the end of each experiment. Animals were then euthanized by iv
injection of 3-M KCl (0.2 ml).

Electrophysiological Recording of Vagal
Bronchopulmonary Afferent Activity
Single-unit activities of vagal bronchopulmonary afferents were
recorded following the protocol modified from our previous
studies in rats (Ho et al., 2001). Briefly, the right cervical vagus
nerve was sectioned, and its caudal end was placed on a small
dissecting platform and immersed in a pool of mineral oil.
A thin filament was teased away from the desheathed nerve
trunk and placed on a platinum-iridium hook electrode. Action
potentials were amplified by a preamplifier (Model P511K, Grass
Technologies, Warwick, RI, USA), and monitored by an audio
monitor (Model AM8RS, Grass Technologies, Warwick, RI,
USA). The thin filament was further split until the afferent
activity arising from a single unit was electrically isolated.
The afferent activity of a pulmonary C-fiber was first searched
by hyperinflation of the lung (PT > 30 cmH2 O) and then
identified by the immediate (delay < 1 s) response to a bolus
iv injection of Cap (1 µg/kg); an example is shown in Figure 1.
RARs and SARs were searched initially by their responses to
hyperinflation of the lung, and then further identified by their
adaptation indexes (AIs) in response to lung inflation; AI was
calculated in each fiber by dividing the difference in fiber
activity (FA) between the first 2 s during a constant-pressure lung
hyperinflation (PT = 30 cmH2 O; e.g., Figure 3) by the FA of the
first second, and expressed as a percentage (Widdicombe, 1954).
Fibers with AIs of <80 and >80% were classified as SARs and
RARs, respectively.
The activity of each sensory nerve was recorded when low
and high doses of iv injections of Cap (0.5–1.0 µg/kg) were
administered with 15–20 min elapsed between two injections.

In-vitro Study
The experiments were carried out in two groups of young
male mice (8–12 week old): 1) wild-type (WT; B6129SF2/J);
2) TNF-receptor double homozygous mutant mice (TNF−/− ;
129S-Tnfrsf1atm1Imx Tnfrsf1btm1Imx /J) in which both types of TNF
receptors, TNFR1 and TNFR2, were mutated. All mice were
purchased from the Jackson Laboratory (Bar Harbor, ME, USA).

Fluorescent Labeling and Isolation of Vagal
Pulmonary Sensory Neurons
Sensory neurons innervating the lungs and airways
were identified by retrograde labeling from the lungs
by using the fluorescent tracer 1,1′ -Dioctadecyl-3,3,3′ ,3′ tetramethylindocarbocyanine perchlorate (DiI, Sigma-Aldrich,
St. Louis, MO, USA; Kwong and Lee, 2002). After a small
midline incision was made on the ventral neck skin of the mouse
during anesthesia with inhalation of vaporized isoflurane (2%
in O2 ), DiI (0.15 mg/ml; 0.025 ml) was instilled into the mouse
trachea and lung via a needle (28 gauge). The incision was then
closed (Vetbond, 3M, St. Paul, MN, USA). Seven to ten days
later, DiI-pretreated animals were anesthetized and decapitated.
The head was immediately immersed in ice-cold DMEM/F-12
solution followed by quick extraction of the jugular-nodose
ganglia complex; as described by Nassenstein et al. (2010), the
mouse jugular and nodose ganglia were fused together in a
single structure, and could not be separated as in larger rodents

FIGURE 1 | Experimental records illustrating the effect of TNFα on the responses of pulmonary C-fibers to capsaicin in anesthetized, open-chest and artificially
ventilated mice. Vehicle (Veh; 0.03 ml of PBS) and TNFα (10 µg/ml, 0.03 ml) were administered by intra-tracheal instillation into the lungs of Veh and TNFα mice,
respectively, ∼24 h earlier. Arrows were added to mark the time when capsaicin (Cap; 1.0 µg/kg) was injected intravenously as a bolus. Both receptor locations were
in the right lung. Body weights of Veh and TNFα mice were 27.8 and 25.9 g, respectively. PT , tracheal pressure; AP, action potential; ABP, arterial blood pressure.
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determine if the effect observed was mediated through the TNF
receptors, TNFR1 and TNFR2, expressed in vagal pulmonary
sensory neurons, the experimental protocols described in Study 1
was repeated in the pulmonary jugular-nodose neurons isolated
from WT and TNF−/− mice that had incubated with 50 ng/ml
of TNFα in culture medium for 24 h; their responses were then
compared.

(e.g., guinea pig, rat). Each ganglion was then desheathed, cut in
smaller pieces, and placed in a mixture of type IV collagenase
(0.04%) and dispase II (0.02%), and incubated for 80 min in
5% CO2 in air at 37◦ C. After digestion, centrifugation and
re-suspension, cells were dissociated by gentle trituration with
small-bore, fire-polished Pasteur pipettes. Myelin debris was
discarded after centrifugation of the dispersed cell suspension
(500 G, 8 min). The cell pellets were resuspended in the modified
DMEM/F-12 solution, plated onto poly-l-lysine-coated glass
coverslips, and then incubated overnight (5% CO2 in air at
37◦ C).

Chemical Agents
All chemicals were purchased from Sigma-Aldrich (St. Louis,
MO, USA), except TNFα (ProSpec-Tany TechnoGene, Rehovot,
Israel), dispase II (Roche, Indianapolis, IN, USA), DMEM/F12 (Invitrogen, Carlsbad, CA, USA), and Fura-2 AM (Life
Technologies, Grand Island, NY, USA). A stock solution of TNFα
(100 µg/ml) was diluted in DMEM/F-12 culture medium to the
desired concentration daily. A stock solution of Cap (1 mM)
was dissolved in 1% Tween 80, 1% ethanol, and 98% saline, and
prepared daily by dilution with PBS and ECS in in-vivo and invitro experiments, respectively. The ECS contained (in mM): 5.4
KCl, 136 NaCl, 1.0 MgCl2 , 1.8 CaCl2 , 0.33 NaH2 PO4 , 10 glucose,
10 HEPES, and a pH level adjusted to 7.4 with NaOH and the
osmolarity to 300 mOsm.

Measurement of Ca2+ Transient in Isolated Mouse
Pulmonary Sensory Neurons
Changes in the intracellular Ca2+ concentration, [Ca2+ ]i , in
isolated pulmonary sensory neurons were measured by the
ratiometric method as reported in our previously study (Gu
et al., 2003). Briefly, cultured cells (as described above) were
washed and maintained in an extracellular solution (ECS). Ca2+
transients were measured in these cells with a digital fluorescence
microscope (Axiovert 100, Carl Zeiss, Thornwood, NY, USA)
equipped with a variable filter wheel (Sutter Instruments, Novato,
CA, USA) and a digital CCD camera (Princeton Instruments,
Trenton, NJ, USA). Cells were incubated with 5-µM Fura2 AM (Life Technologies, Grand Island, NY, USA), a Ca2+
indicator, for 30 min at 37◦ C, rinsed (×3) with ECS and then
allowed to de-esterify for 30 min before use. Dual images
(340- and 380-nm excitation, 510-nm emission) were collected,
and pseudocolor ratiometric images were monitored during the
experiments by using the software Axon Imaging Workbench
(Axon Instruments, Union City, CA, USA; Grynkiewicz et al.,
1985).
The coverslip containing the cells was mounted into a
chamber continuously perfused with an ECS during the
experiment by a gravity-fed valve-controlled system (VC-66CS,
Warner Instruments, Hamden, CT, USA) at a constant rate of ∼2
ml/min. The Fura-2 fluorescence 340/380 ratio was continuously
recorded and analyzed at 2-s intervals, and was converted to
[Ca2+ ]i in nM by the calibration, as described in our previous
study (Hu et al., 2010); the Ca2+ transient was measured as the
difference between the peak amplitude (4-s average) after the
challenge and the baseline (30-s average). A high concentration
of KCl (60 mM, 20-s perfusion) was applied at the end of each
experiment to determine the cell viability. Cells that did not
respond to the KCl challenge were considered non-excitable, and
data were not included for analysis.
Two study series were carried out: Study 1: to determine the
effect of a pretreatment with TNFα on the responses of Ca2+
transient to increasing concentrations of Cap in vagal pulmonary
sensory neurons; two matching dishes of pulmonary jugularnodose ganglia neurons cultured from the same ganglion of
the same mouse were incubated with vehicle (Veh group) and
50 ng/ml of TNFα (TNF group) in culture medium for 24 h,
respectively, and their responses to three concentrations of Cap
(30, 100 and 300 nM; 30 s application and 10 min recovery) were
then determined. This range of Cap concentrations was selected
based upon our previous study (Hu et al., 2010). Study 2: to

Frontiers in Physiology | www.frontiersin.org

Statistical Analysis
Data were compared using either one-way or two-way analysis
of variance (ANOVA), and pair-wise comparisons were made
with a post hoc analysis (Fisher’s least significant difference). P
< 0.05 was considered significant. All data are reported as means
± SEM.

RESULTS
In-vivo Study
A total of 125 vagal bronchopulmonary afferents were studied
in 40 anesthetized, open-chest mice: 17 C-fibers, 37 RARs (24
silent and 13 phasic) and 13 SARs in the Veh group (23 mice
pre-treated with PBS); and 14 C-fibers, 32 RARs (22 silent and 10
phasic) and 12 SARs in the TNF group (17 mice pretreated with
TNFα). Both TNFα and Veh were administered 24–48 h before
the experiments.
In Veh-treated mice, an intravenous bolus injection of
Cap triggered an abrupt (latency <1 s) and short-duration
(3–5 s) of discharge in pulmonary C-fibers (e.g., Figure 1)
accompanied by bradycardia and hypotension, resembling the
pulmonary chemoreflex responses, which were probably elicited
by activation of pulmonary C-fibers conducted by the intact left
vagus nerve. The afferent responses of pulmonary C-fibers to
Cap injections were dose-dependent (Figure 2). In TNFα-treated
mice, the pulmonary C-fiber responses to both low and high
doses of Cap were significantly higher than that in Veh-treated
mice: the 1FA evoked by the low dose of Cap (0.5 µg/kg) was
2.2 ± 0.5 impulses/s (imp/s; n = 11) in the Veh group, and 6.5 ±
1.3 imp/s (n = 12; P < 0.05) in the TNF group; the 1FA evoked
by the high dose of Cap (1.0 µg/kg) was 8.1 ± 1.4 imp/s (n =
17) in the Veh group, and 17.8 ± 2.8 imp/s (n = 14; P < 0.01)
in the TNF group. The Cap injection (1.0 µg/kg) increased PT in
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± 0.7 imp/s (n = 8; P < 0.01) in the TNF group (Figure 5A);
the 1FA evoked by the high dose of Cap (1.0 µg/kg) was 0.4
± 0.1 imp/s (n = 24) in the Veh group, and 2.3 ± 0.5 imp/s (n
= 22; P < 0.01) in the TNF group (Figure 5A). Furthermore,
the number of silent RARs that were activated by Cap injections,
judged by the criterion of 1FA > 1.0 imp/s, was distinctly higher
in TNFα-treated mice: e.g., none of the 9 silent RARs tested were
activated by the low dose of Cap (0.5 µg/kg) in the Veh group,
whereas 6 of the 8 silent RARs were stimulated by the same Cap
injection in the TNF group (Figure 5B). However, there was no
significant difference in the responses of silent RARs to either
lung inflation (P > 0.05) or deflation (P > 0.05) between Vehand TNFα-treated mice (Figures 5C,D).
In comparison, the TNFα pretreatment did not cause any
potentiating effect on the FA responses to the same Cap injection
in phasic RARs: for example, the peak FA after the injection of
high dose of Cap (1.0 µg/kg) was 13.2 ± 4.2 imp/s (n = 13) in the
Veh group, and 11.9 ± 2.2 imp/s (n = 10; P > 0.5) in the TNF
group.
All of the SARs tested in this study exhibited distinct phasic
baseline activity that reached a peak during either inspiratory
or expiratory phase of the respiratory cycles (e.g., Figure 4);
the latter was found in a relatively smaller number of fibers.
The discharge of SARs showed smaller adaptation (AI < 80%)
than RARs during the constant-pressure lung inflation, and their
phasic activity was markedly lowered (e.g., Figure 4) or ceased
completely during lung deflation. The TNFα pretreatment did
not cause any potentiating effect on the FA responses to Cap
injection in SARs: for example, the peak FA after the injection
of high dose of Cap (1.0 µg/kg) was 58.8 ± 8.0 imp/s (n = 13) in
the Veh group, and 43.7 ± 12.3 imp/s (n = 12; P > 0.3) in the
TNF group. There was no significant difference in the response
of SARs to either lung inflation (P > 0.05) or deflation (P > 0.05)
between Veh and TNF groups.

FIGURE 2 | TNFα enhances capsaicin (Cap) sensitivity in pulmonary C-fibers.
Veh (open bars): responses to intravenous bolus injections of Cap 24–48 h
after instillation of vehicle (0.03 ml of PBS). TNF (closed bars): responses to
same doses of Cap 24–48 h after instillation of TNFα (10 µg/ml, 0.03 ml). 1FA:
the increase in fiber activity (FA; impulses/s) from baseline (averaged over the
10-s period immediately preceding the injection) to the peak response
(averaged over 2-s duration) within the first 5 s after the injection. The number
in each bar represents the number of fibers studied under that condition.
*Significantly different from the low dose of Cap (0.5 µg/kg; P < 0.05).
† Significantly different from the Veh group (P < 0.05). Data are means ± SEM.

both TNF and Veh groups, but the 1PT evoked by Cap was not
significantly different between the two groups (P > 0.05).
In Veh-treated (control) mice, pulmonary C-fibers are
relatively insensitive to lung inflation: in general, they were either
not or only weakly stimulated by hyperinflation of the lung (PT
= 30 cmH2 O). This weak response of pulmonary C-fibers to lung
inflation was not altered by the TNFα pretreatment.
RARs exhibited a rapid adaptation to constant-pressure (PT
= 30 cmH2 O maintained for 8 s) lung inflation: AI > 80%
(e.g., Figure 3). They were also activated by lung deflation when
the expiratory line of the respirator was exposed to atmospheric
pressure for 8 s (end-expiratory PT = 0 cmH2 O; e.g., Figures 3,
4). A large percentage of the RARs exhibited distinct phasic
baseline activity that was synchronous with either expiratory
or inspiratory phase of respiratory cycles (e.g., Figure 4). The
remaining RARs had no detectable or very little respiratoryrelated baseline activity (e.g., Figure 3). These two types of RARs
were categorized as phasic RARs and silent RARs in this study.
In Veh-treated (control) mice, injections of Cap even at high
dose (1.0 µg/kg, iv) did not cause significant stimulatory effect
on silent RARs (e.g., Figure 3). However, the responses of these
silent RARs to Cap injections were significantly elevated in
TNFα-treated mice: the 1FA evoked by the low dose of Cap (0.5
µg/kg) was 0.1 ± 0.1 imp/s (n = 9) in the Veh group, and 2.4
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In-vitro Study
A total of 15 WT and 7 TNF−/− mice were used in this study.
Only the cultured jugular-nodose ganglia neurons innervating
the lung structure identified by the DiI fluorescence were selected
for our study. Study 1: In these isolated pulmonary sensory
neurons, Cap evoked a rapid and transient increase in the [Ca2+ ]i
in a concentration-dependent manner (e.g., Figure 6). In the
WT+TNFα neurons incubated with TNFα (50 ng/ml) for ∼24
h, the Cap-evoked increase in [Ca2+ ]i was significantly greater
than that in the WT+Veh neurons (Figure 7A). The difference
in the response of [Ca2+ ]i between these two groups of neurons
was greater at higher concentrations of Cap (e.g., 100 and 300
nM; Figure 7A); 1[Ca2+ ]i evoked by Cap (300 nM, 30 s) was
134.5 ± 44.6 nM in WT+TNFα neurons (n = 114), which was
significantly greater than that in WT+Veh neurons (47.1 ± 9.1
nM, n = 138; P < 0.05). There was no difference in 1[Ca2+ ]i
in response to the lowest dose of Cap (30 nM) between the two
groups. Study 2: When the responses of [Ca2+ ]i to increasing
concentrations of Cap (30, 100 and 300 nM) were compared
between pulmonary sensory neurons isolated from WT mice
and TNF−/− mice after both groups of neurons were incubated
with TNFα (50 ng/ml) for ∼24 h, the Cap-evoked response was
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FIGURE 3 | Experimental records illustrating the effect of TNFα on the responses of silent RARs to capsaicin, inflation and deflation of the lung in two anesthetized,
open-chest and artificially ventilated mice. Veh (0.03 ml of PBS) and TNFα (10 µg/ml, 0.03 ml) were administered ∼24 h earlier by intra-tracheal instillation into the
lungs of Veh and TNFα mice, respectively. (A) Responses to constant pressure (30 cmH2 O) hyperinflations of the lungs for 8 s when the ventilator was turned off.
(B) Responses to lung deflations when the expiratory line of the ventilator was exposed to atmospheric pressure. (C) Responses to intravenous bolus injections of
capsaicin (1.0 µg/kg) at arrows. Both receptor locations were in the right lung. Body weights of Veh and TNFα mice were 31.8 and 25.9 g, respectively. Notice that in
the TNFα-pretreated mouse in (C) a pulmonary C-fiber (with a smaller amplitude of AP) was also stimulated by Cap injection, but was not activated by either lung
inflation or deflation. PT , tracheal pressure; AP, action potential; ABP, arterial blood pressure.

markedly attenuated in the TNF−/− neurons (e.g., Figure 6); this
difference in the response of [Ca2+ ]i between these two groups
of neurons was greater at the higher concentrations of Cap (300
nM; Figure 7B): 1[Ca2+ ]i = 74.8 ± 12.3 nM (n = 191) in the
TNF−/− +TNFα group, and 143.2 ± 46.0 nM (n = 111; P < 0.05)
in the WT+TNFα group. In this WT+TNFα group, 76 neurons
were also included in the data presented in Figure 7A.

exhibited no or very little Cap sensitivity in the Veh-treated mice.
Furthermore, the increased sensitivity to Cap was also present
in the isolated pulmonary sensory neurons, indicating that the
sensitizing effect is mediated primarily through a direct action of
TNFα on these neurons. The fact that this effect was attenuated
in TNF−/− neurons further suggests the involvement of TNF
receptors.
The afferent properties and functions of the three major
types of vagal bronchopulmonary sensory receptors have been
described extensively in several animal species including dog,
cat, rabbit, guinea pig, and rat (Coleridge and Coleridge, 1984;
Lee and Yu, 2014; Mazzone and Undem, 2016). In more
recent years, valuable information about the characterization
and classifications of these vagal airway afferents in mice have
been reported (Kollarik and Undem, 2004; Zhang et al., 2006;
Lin et al., 2011), which have paved the road for realizing the

DISCUSSION
Results of this study showed that instillation of TNFα into the
lung 24–48 h earlier induced a distinct increase in the sensitivity
of vagal pulmonary C-fibers to Cap in anesthetized mice. More
interestingly, the TNFα pretreatment also clearly elevated the
sensitivity of silent RARs to Cap; in stark contrast, silent RARs
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FIGURE 4 | Experimental records illustrating the effect of TNFα on the responses of a phasic rapidly adapting receptor (ph-RAR) and a slowly adapting receptor (SAR)
to capsaicin, inflation and deflation of the lung in an anesthetized, open-chest and artificially ventilated mouse. TNFα (10 µg/ml, 0.03 ml) was administered by
intra-tracheal instillation into the lungs of the mouse ∼24 h earlier. (A) Responses to constant pressure (30 cmH2 O) hyperinflations of the lungs for 8 s when the
ventilator was turned off. (B) Responses to lung deflations when the expiratory line of the ventilator was exposed to atmospheric pressure. (C) Responses to
intravenous bolus injections of capsaicin (1.0 µg/kg) at arrows. Both receptor locations were in the right lung. Body weight of the mouse was 24.2 g. PT , tracheal
pressure; AP, action potential; ABP, arterial blood pressure.

RARs in the TNFα-treated mice. Questions regarding the reflex
responses elicited by activation of these silent RARs still remain
to be answered, as a distinct TRPV1 sensitivity emerged in these
airway afferents after the TNFα treatment. The firing behavior of
these silent RARs exhibited certain features resembling the “highthreshold Aδ vagal afferents” described by Lin et al. (2011); for
example, they displayed a very mild sensitivity to Cap and other
chemical stimulants of C-fibers (e.g., sulfur dioxide; data not
shown), and did not exhibit phasic discharge during mechanical
ventilation. In addition, we cannot rule out the possibility that
these RARs are the cough receptors that have been identified
in other species by previous investigators (Widdicombe, 1954;
Canning et al., 2004). These silent RARs appear to be less
frequently found and may represent a minority subgroup of the
RARs though we did not attempt to determine their percentage
distribution in this study.

promising potential of various transgenic and knockout mouse
models in advancing our knowledge about the physiological
function of airway sensory receptors (Nassenstein et al., 2010;
Nonomura et al., 2017). Results obtained in this study from the
control (Veh) mice were in general agreement with what have
been reported by other investigators in this species; both SARs
and phasic RARs are typical mechanoreceptors; they discharged
phasically and synchronously with the respiratory cycles of
the ventilator, and responded vigorously and consistently to
lung inflation and/or deflation. The “intermediate receptors”
described by previous investigators Zhang et al. (2006) were also
categorized as SARs due to the standard AI criterion adopted in
our study. Intravenous bolus injection of Cap did not evoke any
significant stimulatory effect on SARs and phasic RARs in either
Veh- or TNFα-treated mice. In sharp contrast, the same Cap
challenge evoked a pronounced stimulatory effect on the silent
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FIGURE 5 | Continued
(PT = 30 cmH2 O); 1FA: the difference in FA between the FA during the first
second of lung inflation and the baseline (averaged over the 10-s period
preceding inflation). (D) Response to lung deflation; 1FA: the difference
between the FA averaged over the 8-s duration of deflation and the baseline
(averaged over the 10-s period preceding the deflation). *Significantly different
from the Veh group (P < 0.05).

Vagal C-fiber afferents represent the major type of the sensory
nerves arising from the lung and airways (Jammes et al., 1982)
and innervate the entire respiratory tract in various mammalian
species including mice (Coleridge and Coleridge, 1984; Watanabe
et al., 2006; Nassenstein et al., 2010; Lee and Yu, 2014). The
afferent activity generated by these C-fiber endings plays a
significant role in eliciting the pulmonary defense reflexes in
both healthy and disease conditions (Coleridge and Coleridge,
1984; Lee and Yu, 2014). When these afferent endings are
activated by either inhaled chemical irritants or endogenous
inflammatory mediators, they can evoke respiratory sensations
such as airway irritation, urge to cough, and dyspnea (Burki and
Lee, 2010; Lee and Yu, 2014). In addition, it elicits powerful reflex
responses including cough, airway smooth muscle contraction,
bronchial vasodilation, and mucous hypersecretion (Coleridge
and Coleridge, 1984; Lee and Pisarri, 2001); Intense and/or
sustained stimulation of these afferents causes “neurogenic
inflammation” in the tracheobronchial tree: extravasation of
macromolecules and inflammatory cell chemotaxis. These airway
responses are known to be generated through activations of both
the cholinergic reflex pathways and the local “axonal reflex;”
the latter involves the release of several bioactive tachykinins
and calcitonin gene-related peptides from these sensory endings
(Baluk et al., 1992; De Swert and Joos, 2006). Although we did
not measure these responses in this study, it seems plausible
and logic to postulate that when the C-fiber afferent sensitivity
is elevated by an increase in the endogenously released TNFα,
these airway reflex responses to a given stimulus will be
intensified.
An important role of TNFα in the pathogenesis of allergic
inflammatory diseases such as asthma has been extensively
documented (Thomas, 2001; Howarth et al., 2005; Berry et al.,
2006; Heffler et al., 2007; Brightling et al., 2008). TNFα
was detected in bronchoalveolar lavage fluid, exhaled breath
condensate and sputum of asthmatic patients during acute
exacerbation or after antigen inhalation challenge in these
patients (Keatings et al., 1997; Matsunaga et al., 2006). TNFα
is released from a variety of cell types in the airways, such
as mast cells and macrophages, via the immunoglobulin Edependent mechanism (Gosset et al., 1992; Cembrzynska-Nowak
et al., 1993; Thomas, 2001; Brightling et al., 2008). Once
released, TNFα can exert multiple potent effects on a number
of effector cells and induce the inflammatory reaction in the
airways. Inhalation of aerosolized TNFα can also induce airway
hyperresponsiveness accompanied by airway inflammation in
healthy human volunteers (Thomas et al., 1995). Results of
this study suggest that our finding of the TNFα-induced
hypersensitivity of bronchopulmonary C-fiber afferents may be

FIGURE 5 | TNFα enhances capsaicin sensitivity in silent RARs: a comparison
between Veh (open bars) and TNF group (closed bars). (A) Responses to Cap
injections (0.5–1.0 µg/kg); 1FA: the increase in fiber activity (FA; impulses/s)
from baseline (averaged over the 10-s period immediately preceding the
injection) to the peak response (averaged over 2-s duration) within the first 5 s
after the injection. (B) Percentages of silent RARs that exhibited Cap sensitivity
(1FA > 1.0 imp/s after Cap injection). (C) Response to lung hyperinflation
(Continued)
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FIGURE 6 | Representative experimental records illustrating the change in [Ca2+ ]i evoked by increasing concentrations of capsaicin (Cap) in vagal pulmonary sensory
neurons. Left panel: a pulmonary neuron (diameter: 24 µm) isolated from a wild-type (WT) mouse; Right panel: a pulmonary neuron (diameter: 22 µm) isolated from
a TNF-receptor double homozygous mutant (TNF−/− ) mouse. Both WT and TNF−/− neurons had been incubated with TNFα (50 ng/ml in culture medium) for ∼24 h.
Cap was applied for 30 s each, and KCl solution (60 mM, 20 s) was applied to test cell vitality at the end of each experiment.

FIGURE 7 | Potentiating effect of TNFα (50 ng/ml, ∼24 h) on Cap-evoked calcium transient in pulmonary sensory neurons isolated from WT and TNF−/− mice. (A) A
comparison of the responses of [Ca2+ ]i to increasing concentrations of Cap between Veh- and TNFα-treated neurons isolated from wild-type (WT) mice. *Significantly
different from the corresponding response to 30 nM capsaicin (P < 0.05). † Significantly different from the corresponding data in Veh-treated neurons (P < 0.05).
(B) The effect of TNFα treatment on the [Ca2+ ]i responses to increasing concentrations of Cap in neurons isolated from WT and TNF−/− mice. In the WT+TNFα
group, 76 neurons were also included as part of the data presented in (A). Data are mean ± SEM. *Significantly different from the corresponding response to 30 nM
capsaicin (P < 0.05). † Significantly different from the corresponding data in TNF−/− neurons (P < 0.05).

a wide range of immunological responses and inflammatory
reactions (Brockhaus et al., 1990; Tartaglia and Goeddel, 1992;
Baud and Karin, 2001; Utreras et al., 2009). TNFα is initially
produced as a membrane-anchored precursor protein, and
subsequently cleaved into free proteins, which form biologically
active homotrimers and interact with these TNFRs. TNFα can
act in a paracrine manner on epithelial cells in promoting the
transmigration of leukocytes via a TNFR1-dependent signaling
pathway (Morton et al., 2016). Activation of TNFR1 is also

involved, at least in part, in the development of the airway
hyperresponsiveness.
The mechanism(s) underlying the potentiating effect of TNFα
on these vagal bronchopulmonary sensory nerves in this study is
not yet fully understood. TNFα is known to exert its biological
effects via a direct action on TNFR1 and TNFR2 that are
present on a wide variety of cell types in the airways (Heffler
et al., 2007). Upon activation by TNFα, these TNF receptors
can actuate several signaling pathways that are involved in
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mechanism may involve the expression of TRPV1 on the sensory
terminals of the silent RARs induced by the TNFα treatment.
Activation of TRPV1 by the Cap injection may then trigger
Ca2+ influx and lead to subthreshold depolarization of the
terminal membrane. In addition, the presence of Cap can shift the
TRPV1 channel activation curve (open probability vs. voltage)
to a physiologically relevant voltage range with a relatively small
gating charge (Voets et al., 2004). Both of these actions generated
by Cap can increase the membrane excitability. Thus, a belowthreshold stimulus to the mechanosensitive channels, such as a
lung expansion during the inspiratory cycle of the ventilator, may
trigger the firing of action potentials at the sensory terminals of
these silent RARs.
In conclusion, this study demonstrated that the intratracheal instillation of TNFα 1–2 days earlier significantly
enhanced the sensitivity of pulmonary C-fibers to Cap and
upregulated the TRPV1 sensitivity in a subgroup of RARs.
However, the underlying mechanism of the TNFα-induced
change in the TRPV1 sensitivity of these afferents is still
not yet fully understood. As this study has established the
evidence of this sensitizing effect in mice, the potential
involvements of certain TNFR-mediated signaling pathways
(discussed earlier) can be further explored in the transgenic and
knockout mouse models. Considering the increasing evidence
suggesting a possible involvement of the TRPV1 channel
in the manifestation of a number of symptoms of airway
hypersensitivity during inflammatory reaction, a possible impact
of the sensitizing effects of TNFα on these airway afferents
and their regulation of overall cardiopulmonary functions in
allergic airway inflammatory diseases certainly merits further
investigations.

known to activate nuclear factor-kappa B (Furukawa and
Mattson, 1998) and mitogen activated protein kinases (MAPK)
pathways, including the extracellular signal-regulated kinase
(ERK; Barbin et al., 2001). Hensellek and coworkers (Hensellek
et al., 2007) have demonstrated that exposure of DRG neurons
to TNFα for 24–48 h significantly increased the proportion of
DRG neurons expressing TRPV1 receptor-like immunoreactivity
via TNFR1 and the ERK activation. Furthermore, it has
been shown that activation of p38 MAPK pathway increased
TRPV1 expression in peripheral nociceptor neurons in a
transcription-independent manner (Ji et al., 2002). Indeed, our
immunohistochemical study has previously demonstrated the
presence of both TNFR1 and TNFR2 on the cell membrane
of rat vagal pulmonary sensory neurons (Hu et al., 2010).
Results obtained in the present study showing that the sensitizing
effect of TNFα was attenuated in isolated TNF−/− neurons
lend an additional support to this hypothesis. In addition,
activation of TNFRs can also cause a chemotactic action,
upregulate the leukocyte-endothelial cell adhesive molecules,
enhance the production of Th2 cytokines and cause infiltration
and degranulation of these inflammatory cells in the airways
(Kips et al., 1992; Bradding et al., 1994; Thomas et al., 1995;
Thomas, 2001; Nakae et al., 2007). Thus, these actions of
TNFα can evoke releases of other inflammatory mediators, and
some of these autacoids such as histamine, leukotrienes, and
thromboxanes (Lin et al., 2013) are known to exert pronounced
sensitizing effects on vagal bronchopulmonary C-fiber afferents
(Lee and Yu, 2014).
Another interesting observation should be further elaborated.
When the silent RARs were activated by Cap injection in TNFαtreated mice, the evoked fiber activity was frequently phasic and
synchronous with the inspiratory cycles of the ventilator (e.g.,
Figure 3C); this phasic discharge pattern was distinctly different
from that in C-fiber response to Cap (e.g., Figure 1). We don’t
believe that the phasic activity was related to bronchoconstriction
because the discharge occurred immediately (in 1–2 s) after the
Cap injection when there was no detectable change in peak
tracheal (e.g., Figure 3C). Furthermore, the TNFα treatment
did not increase the response to lung inflation in silent RARs.
Interestingly, in the TNFα-treated mice the phasic activity of
these RARs was only found during the short interval immediately
following the Cap injection, similar to the duration and time
course of the C-fiber response. We suggest that a possible

AUTHOR CONTRIBUTIONS
All three authors, RL, QG, and LL, are responsible for designing
the study, performing experiments, collecting, analyzing, and
interpretation of the data, and preparation of the manuscript.

ACKNOWLEDGMENTS
The authors thank Marcus Greer and Ashami Athukorala for
their technical assistances. This study was supported in part by
NIH grants AI123832, HL96914, and UL1TR001998.

REFERENCES

Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., et al.
(2006). Evidence of a role of tumor necrosis factor alpha in refractory asthma.
N. Engl. J. Med. 354, 697–708. doi: 10.1056/NEJMoa050580
Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R.,
Mueller, R., et al. (1994). Interleukin-4, -5, and -6 and tumor necrosis factoralpha in normal and asthmatic airways: evidence for the human mast cell
as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10, 471–480.
doi: 10.1165/ajrcmb.10.5.8179909
Brightling, C., Berry, M., and Amrani, Y. (2008). Targeting TNF-alpha: a novel
therapeutic approach for asthma. J. Allergy Clin. Immunol. 121, 5–10; quiz
11–12. doi: 10.1016/j.jaci.2007.10.028
Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W.,
and Loetscher, H. (1990). Identification of two types of tumor necrosis factor

Baluk, P., Nadel, J. A., and McDonald, D. M. (1992). Substance P-immunoreactive
sensory axons in the rat respiratory tract: a quantitative study of their
distribution and role in neurogenic inflammation. J. Comp. Neurol. 319,
586–598. doi: 10.1002/cne.903190408
Barbin, G., Roisin, M. P., and Zalc, B. (2001). Tumor necrosis factor alpha
activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary
cultures of neurons. Neurochem. Res. 26, 107–112. doi: 10.1023/A:10110864
26652
Baud, V., and Karin, M. (2001). Signal transduction by tumor necrosis factor
and its relatives. Trends Cell Biol. 11, 372–377. doi: 10.1016/S0962-8924(01)0
2064-5

Frontiers in Physiology | www.frontiersin.org

10

June 2017 | Volume 8 | Article 411

Lin et al.

Hypersensitivity of Pulmonary Afferents Induced by TNFα

Keatings, V. M., O’Connor, B. J., Wright, L. G., Huston, D. P., Corrigan, C. J.,
and Barnes, P. J. (1997). Late response to allergen is associated with increased
concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. J.
Allergy Clin. Immunol. 99, 693–698. doi: 10.1016/S0091-6749(97)70032-0
Kips, J. C., Tavernier, J., and Pauwels, R. A. (1992). Tumor necrosis factor causes
bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145(2 Pt 1),
332–336. doi: 10.1164/ajrccm/145.2_Pt_1.332
Kollarik, M., and Undem, B. J. (2004). Activation of bronchopulmonary
vagal afferent nerves with bradykinin, acid and vanilloid receptor
agonists in wild-type and TRPV1−/− mice. J. Physiol. 555(Pt 1), 115–123.
doi: 10.1113/jphysiol.2003.054890
Kwong, K., and Lee, L. Y. (2002). PGE sensitizes cultured pulmonary vagal
sensory neurons to chemical and electrical stimuli. J. Appl. Physiol. (1985) 93,
1419–1428. doi: 10.1152/japplphysiol.00382.2002
Lee, L. Y., and Gu, Q. (2009). Role of TRPV1 in inflammationinduced airway hypersensitivity. Curr. Opin. Pharmacol. 9, 243–249.
doi: 10.1016/j.coph.2009.02.002
Lee, L. Y., and Pisarri, T. E. (2001). Afferent properties and reflex
functions of bronchopulmonary C-fibers. Respir. Physiol. 125, 47–65.
doi: 10.1016/S0034-5687(00)00204-8
Lee, L. Y., and Yu, J. (2014). Sensory nerves in lung and airways. Compr. Physiol. 4,
287–324. doi: 10.1002/cphy.c130020
Lin, R. L., Lin, Y. J., Geer, M. J., Kryscio, R., and Lee, L. Y. (2013). Pulmonary
chemoreflex responses are potentiated by tumor necrosis factor-alpha in
mice. J. Appl. Physiol. (1985) 114, 1536–1543. doi: 10.1152/japplphysiol.01301.
2012
Lin, S., Li, H., Xu, L., Moldoveanu, B., Guardiola, J., and Yu, J. (2011). Arachidonic
acid products in airway nociceptor activation during acute lung injury. Exp.
Physiol. 96, 966–976. doi: 10.1113/expphysiol.2011.058263
Matsunaga, K., Yanagisawa, S., Ichikawa, T., Ueshima, K., Akamatsu, K.,
Hirano, T., et al. (2006). Airway cytokine expression measured by means
of protein array in exhaled breath condensate: correlation with physiologic
properties in asthmatic patients. J. Allergy Clin. Immunol. 118, 84–90.
doi: 10.1016/j.jaci.2006.04.020
Mazzone, S. B., and Undem, B. J. (2016). Vagal afferent innervation
of the airways in health and disease. Physiol. Rev. 96, 975–1024.
doi: 10.1152/physrev.00039.2015
Morton, P. E., Hicks, A., Ortiz-Zapater, E., Raghavan, S., Pike, R., Noble,
A., et al. (2016). TNFalpha promotes CAR-dependent migration of
leukocytes across epithelial monolayers. Sci. Rep. 6:26321. doi: 10.1038/srep
26321
Nakae, S., Ho, L. H., Yu, M., Monteforte, R., Iikura, M., Suto, H., et al. (2007). Mast
cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2
cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120,
48–55. doi: 10.1016/j.jaci.2007.02.046
Nassenstein, C., Taylor-Clark, T. E., Myers, A. C., Ru, F., Nandigama, R., Bettner,
W., et al. (2010). Phenotypic distinctions between neural crest and placodal
derived vagal C-fibres in mouse lungs. J. Physiol. 588(Pt 23), 4769–4783.
doi: 10.1113/jphysiol.2010.195339
Nicol, G. D., Lopshire, J. C., and Pafford, C. M. (1997). Tumor necrosis factor
enhances the capsaicin sensitivity of rat sensory neurons. J. Neurosci. 17,
975–982.
Nilius, B., Owsianik, G., Voets, T., and Peters, J. A. (2007). Transient
receptor potential cation channels in disease. Physiol. Rev. 87, 165–217.
doi: 10.1152/physrev.00021.2006
Nonomura, K., Woo, S. H., Chang, R. B., Gillich, A., Qiu, Z., Francisco,
A. G., et al. (2017). Piezo2 senses airway stretch and mediates lung
inflation-induced apnoea. Nature 541, 176–181. doi: 10.1038/nature
20793
Tartaglia, L. A., and Goeddel, D. V. (1992). Two TNF receptors. Immunol. Today
13, 151–153. doi: 10.1016/0167-5699(92)90116-O
Thomas, P. S. (2001). Tumour necrosis factor-alpha: the role of this
multifunctional cytokine in asthma. Immunol. Cell Biol. 79, 132–140.
doi: 10.1046/j.1440-1711.2001.00980.x
Thomas, P. S., Yates, D. H., and Barnes, P. J. (1995). Tumor necrosis
factor-alpha increases airway responsiveness and sputum neutrophilia in
normal human subjects. Am. J. Respir. Crit. Care Med. 152, 76–80.
doi: 10.1164/ajrccm.152.1.7599866

receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci.
U.S.A. 87, 3127–3131. doi: 10.1073/pnas.87.8.3127
Burki, N. K., and Lee, L. Y. (2010). Mechanisms of dyspnea. Chest 138, 1196–1201.
doi: 10.1378/chest.10-0534
Canning, B. J., Mazzone, S. B., Meeker, S. N., Mori, N., Reynolds, S. M., and
Undem, B. J. (2004). Identification of the tracheal and laryngeal afferent
neurones mediating cough in anaesthetized guinea-pigs. J. Physiol. 557(Pt 2),
543–558. doi: 10.1113/jphysiol.2003.057885
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., and
Julius, D. (1997). The capsaicin receptor: a heat-activated ion channel in the
pain pathway. Nature 389, 816–824. doi: 10.1038/39807
Cembrzynska-Nowak, M., Szklarz, E., Inglot, A. D., and Teodorczyk-Injeyan, J. A.
(1993). Elevated release of tumor necrosis factor-alpha and interferon-gamma
by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev.
Respir. Dis. 147, 291–295. doi: 10.1164/ajrccm/147.2.291
Coleridge, J. C., and Coleridge, H. M. (1984). Afferent vagal C fibre innervation
of the lungs and airways and its functional significance. Rev. Physiol. Biochem.
Pharmacol. 99, 1–110. doi: 10.1007/BFb0027715
Cunha, F. Q., Poole, S., Lorenzetti, B. B., and Ferreira, S. H. (1992).
The pivotal role of tumour necrosis factor alpha in the development
of inflammatory hyperalgesia. Br. J. Pharmacol. 107, 660–664.
doi: 10.1111/j.1476-5381.1992.tb14503.x
De Swert, K. O., and Joos, G. F. (2006). Extending the understanding
of sensory neuropeptides. Eur. J. Pharmacol. 533, 171–181.
doi: 10.1016/j.ejphar.2005.12.066
Furukawa, K., and Mattson, M. P. (1998). The transcription factor NFkappaB mediates increases in calcium currents and decreases in
NMDA- and AMPA/kainate-induced currents induced by tumor necrosis
factor-alpha in hippocampal neurons. J. Neurochem. 70, 1876–1886.
doi: 10.1046/j.1471-4159.1998.70051876.x
Geppetti, P., Materazzi, S., and Nicoletti, P. (2006). The transient receptor potential
vanilloid 1: role in airway inflammation and disease. Eur. J. Pharmacol. 533,
207–214. doi: 10.1016/j.ejphar.2005.12.063
Gosset, P., Tsicopoulos, A., Wallaert, B., Joseph, M., Capron, A., and Tonnel,
A. B. (1992). Tumor necrosis factor alpha and interleukin-6 production by
human mononuclear phagocytes from allergic asthmatics after IgE-dependent
stimulation. Am. Rev. Respir. Dis. 146, 768–774. doi: 10.1164/ajrccm/146.3.768
Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985). A new generation of Ca2+
indicators with greatly improved fluorescence properties. J. Biol. Chem. 260,
3440–3450.
Gu, Q., Kwong, K., and Lee, L. Y. (2003). Ca2+ transient evoked by chemical
stimulation is enhanced by PGE2 in vagal sensory neurons: role of cAMP/PKA
signaling pathway. J. Neurophysiol. 89, 1985–1993. doi: 10.1152/jn.00748.2002
Heffler, E., Berry, M., and Pavord, I. D. (2007). Tumor necrosis factoralpha: a promising therapeutic target for asthma? BioDrugs 21, 345–349.
doi: 10.2165/00063030-200721060-00002
Hensellek, S., Brell, P., Schaible, H. G., Brauer, R., and Segond von Banchet, G.
(2007). The cytokine TNFalpha increases the proportion of DRG neurones
expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation.
Mol. Cell. Neurosci. 36, 381–391. doi: 10.1016/j.mcn.2007.07.010
Ho, C. Y., Gu, Q., Lin, Y. S., and Lee, L. Y. (2001). Sensitivity of vagal afferent
endings to chemical irritants in the rat lung. Respir. Physiol. 127, 113–124.
doi: 10.1016/S0034-5687(01)00241-9
Howarth, P. H., Babu, K. S., Arshad, H. S., Lau, L., Buckley, M., McConnell,
W., et al. (2005). Tumour necrosis factor (TNFalpha) as a novel therapeutic
target in symptomatic corticosteroid dependent asthma. Thorax 60, 1012–1018.
doi: 10.1136/thx.2005.045260
Hu, Y., Gu, Q., Lin, R. L., Kryscio, R., and Lee, L. Y. (2010). Calcium transient
evoked by TRPV1 activators is enhanced by tumor necrosis factor-{alpha} in
rat pulmonary sensory neurons. Am. J. Physiol. Lung Cell. Mol. Physiol. 299,
L483–L492. doi: 10.1152/ajplung.00111.2010
Jammes, Y., Fornaris, E., Mei, N., and Barrat, E. (1982). Afferent and efferent
components of the bronchial vagal branches in cats. J. Auton. Nerv. Syst. 5,
165–176. doi: 10.1016/0165-1838(82)90037-6
Ji, R. R., Samad, T. A., Jin, S. X., Schmoll, R., and Woolf, C. J. (2002). p38
MAPK activation by NGF in primary sensory neurons after inflammation
increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36, 57–68.
doi: 10.1016/S0896-6273(02)00908-X

Frontiers in Physiology | www.frontiersin.org

11

June 2017 | Volume 8 | Article 411

Lin et al.

Hypersensitivity of Pulmonary Afferents Induced by TNFα

Utreras, E., Futatsugi, A., Rudrabhatla, P., Keller, J., Iadarola, M. J., Pant,
H. C., et al. (2009). Tumor necrosis factor-alpha regulates cyclindependent kinase 5 activity during pain signaling through transcriptional
activation of p35. J. Biol. Chem. 284, 2275–2284. doi: 10.1074/jbc.M8050
52200
Voets, T., Droogmans, G., Wissenbach, U., Janssens, A., Flockerzi, V., and Nilius,
B. (2004). The principle of temperature-dependent gating in cold- and heatsensitive TRP channels. Nature 430, 748–754. doi: 10.1038/nature02732
Watanabe, N., Horie, S., Michael, G. J., Keir, S., Spina, D., Page, C. P., et al.
(2006). Immunohistochemical co-localization of transient receptor potential
vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory
system. Neuroscience 141, 1533–1543. doi: 10.1016/j.neuroscience.2006.04.073
Widdicombe, J. G. (1954). Receptors in the trachea and bronchi of the cat. J.
Physiol. (Lond) 123, 71–104. doi: 10.1113/jphysiol.1954.sp005034
Zhang, G., Lin, R. L., Wiggers, M., Snow, D. M., and Lee, L. Y. (2008). Altered
expression of TRPV1 and sensitivity to capsaicin in pulmonary myelinated

Frontiers in Physiology | www.frontiersin.org

afferents following chronic airway inflammation in the rat. J. Physiol. (Lond)
586, 5771–5786. doi: 10.1113/jphysiol.2008.161042
Zhang, J. W., Walker, J. F., Guardiola, J., and Yu, J. (2006). Pulmonary sensory
and reflex responses in the mouse. J. Appl. Physiol. (1985) 101, 986–992.
doi: 10.1152/japplphysiol.00161.2006
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Lin, Gu and Lee. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.

12

June 2017 | Volume 8 | Article 411

